We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.65% | 6.24 | 5.68 | 6.50 | 6.24 | 6.18 | 6.22 | 365,977 | 16:25:23 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.71 | 12.56M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 12/4/2021 17:27 | Mutations getting more complex too...vaccines will have a job to keep up the pace...the battle continues unabated. | allin | |
| 12/4/2021 17:22 | WHO says Covid growing exponentially at 4.4millions new cases per week across the world even 16 months into the virus discovery. Still a market for SNG. | allin | |
| 12/4/2021 14:49 | Nobby or any chemists out there ,it seems that Moderna and Pfizer both have their drawbacks not just the AZN red flags. What do you think of the likelihood of AZN being offered if you have already had one jab of it? Moderna I already had some concerns about because of the side effects for use in Malaria prevention. | hazl |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
